MedPath

Subacromial injection of tranexamic acid improves early postoperative range of motion in arthroscopic rotator cuff repair: a prospective randomized controlled trial

Phase 2
Conditions
Rotator cuff injury
arthroscopic rotator cuff repair,
subacromial injection,
tranexamic acid
Registration Number
TCTR20210530002
Lead Sponsor
/A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
62
Inclusion Criteria

Patients diagnosed with a rotator cuff tear.

Exclusion Criteria

1. Allergic to tranexamic acid, 2. Had undergone previous rotator cuff repair, 3. Irreparable rotator cuff tears, 4. Had a history of deep vein thrombosis, 5. Had a history of pulmonary embolism, 6. Had a history of stroke, 7. coronary artery disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postoperative shoulder range of motion 2, 6, and 12 weeks postoperatively Smartphone clinometers
Secondary Outcome Measures
NameTimeMethod
Postoperative pain 24 hours postoperatively Visual analog scale
© Copyright 2025. All Rights Reserved by MedPath